NCT04923217

Brief Summary

Mayer-Rokitansky-Kuster-Hauser(MRKH) syndrome is described as absence or underdevelopment of vagina and uterus. This condition is extremely rare congenital malformation that affects one in every 5000 female births. Medical management of MRKH syndrome includes the creation of a neovagina using nonsurgical or surgical procedure. In Vietnam, since 2014, Davydov technique has been used to create neovagina for patients with MRKH syndrome at Tu Du hospital which is the biggest obstetric and gynecological hospital in south of Vietnam. However, the effectiveness of this surgical approach on patient's life and sexual activity hasn't been assessed. The objective of this study is to assess the quality of life, the psychological impact and the sexual function of Vietnamese women with MRKH syndrome after Davydov surgical procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2021

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 11, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

December 13, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2022

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2022

Completed
Last Updated

November 18, 2022

Status Verified

November 1, 2022

Enrollment Period

3 months

First QC Date

May 21, 2021

Last Update Submit

November 14, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Quality of Life of women with vaginal agenesis after Davydov procedure

    The psychological doctor uses the questionnaire named World Health Organization Quality of Life Scale(WHOQoL-BREF) in the interview to ask patient. The patient's Quality of Life will be assessed based on the WHOQoL-BREF questionnaire 's score. All the results will be collected and calculated subsequently. The raw scores are converted to transformation scores. The first transformation converts scores to range of 4-20 and the second transformation converts domain scores to 0-100 scale. Higher scores reflect better Quality of Life.

    From six months after surgery up to the initiation of the study, assessed up to 1 month

  • Sexual Function of women with vaginal agenesis after Davydov procedure

    The psychological doctor uses the questionnaire named Female Sexual Function Index Scale (FSFI) in the interview to ask patient. The patient's sexual function will be assessed based on the FSFI questionnaire 's score. All the results will be collected and calculated subsequently. The FSFI's minimum total score is 2 and the FSFI's maximum total score is 36. The patient is diagnosed to have sexual dysfunction when the FSFI's total score is less than 26,55.

    From six months after surgery up to the initiation of the study, assessed up to 1 month

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Sample is patients who underwent Davydov procedure to create neovagina at Tu Du hospital, Ho Chi Minh city, Vietnam.

You may qualify if:

  • Aged equal or more than 18.
  • Diagnosed vaginal agenesis and underwent Davydov procedure to create neovagina at least 6 months.
  • Able to listen, understand and answer questions.

You may not qualify if:

  • Disagreed to participate the research.
  • Having any conditions that make patient unable to listen, understand and answer questions.
  • Having psychological disturbance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tu Du Hospital

Ho Chi Minh City, Vietnam

Location

MeSH Terms

Conditions

Mullerian aplasiaSexual Dysfunctions, Psychological

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Lan TN Vuong, PhD

    University of Medicine and Pharmacy at Ho Chi Minh City

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

May 21, 2021

First Posted

June 11, 2021

Study Start

December 13, 2021

Primary Completion

February 28, 2022

Study Completion

November 10, 2022

Last Updated

November 18, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations